A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 | NEJM
Original Article from The New England Journal of Medicine — A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
Related Articles
Digital Diabetes Management Solutions – Peterson Health Technology Institute
PHTI conducted an evaluation of digital diabetes management tools that support improved glycemic control in people with type 2 diabetes.
Health Tech: Charting ambient scribes
High-tech medical scribes promise to revitalize the low-tech doctor’s appointment, but their pricing and accuracy vary, according to an Axios analysis.
Fear of COVID fades even as virus remains a ‘significant threat,’ survey reveals
A new survey shows a major shift in Americans’ COVID-19 concerns and vaccine…
Exclusive: UCSF to pay $100 million to acquire two struggling S.F. hospitals
UCSF’s acquisition of St. Mary’s Medical Center and Saint Francis Memorial Hospital…
Generative AI in Healthcare: Is This our Hemingway Moment?
In this week’s Medical Grand Rounds, Bob Wachter, chair of the UCSF Department of Medicine and author of the bestselling book, The Digital Doctor: Hope,…
Nancy E. Adler, Who Linked Wealth to Health, Dies at 77
She documented the powerful role that education, income and self-perceived social status play in a person’s health and longevity.
COVID-19 and Patient Safety
This Viewpoint examines the similarities between medical errors and COVID-19 and discusses lessons applicable to ongoing and emerging health challenges.
SOTP: State-of-the-Pandemic
The pandemic’s 2nd biggest wave of infections and what the JN.1 variant is telling us